
Détail de l'auteur
Auteur C. LIONS |
Documents disponibles écrits par cet auteur (7)

![]()
Article : Périodique
B. ROLLAND ; C. LIONS ; V. DI BEO ; P. CARRIERI ; N. AUTHIER ; T. BARRE ; J. DELORME ; P. MATHURIN ; F. BAILLY ; C. PROTOPOPESCU ; F. MARCELLIN |Background: Opioid agonist therapy (OAT) is associated with reduced injection, reduced HCV transmission, and more opportunities to initiate hepatitis C virus (HCV) treatment in people who use drugs (PWUD). We aimed to study the extent to which a[...]![]()
Article : Périodique
P. CARRIERI ; A. VILOTITCH ; S. NORDMANN ; C. LIONS ; L. MICHEL ; M. MORA ; A. MOREL ; G. MARADAN ; B. SPIRE ; P. ROUX |Background: Patients receiving buprenorphine who are poor responders can continue to commit drug-related offences. Switching them from buprenorphine to methadone may result in reduced criminal behaviour. We compared self-reported offences and in[...]Nouveauté
![]()
Article : Périodique
P. ROUX ; C. LIONS ; M. P. CARRIERI |Evidence-based research has underlined both the need to increase access to care for people who use drugs (PWUD) and to "normalize" care for drug dependence as a means to control health risks (Connock et al., 2007; Mattick, Breen, Kimber, & Davol[...]![]()
Article : Périodique
P. ROUX ; J. M. LE GALL ; M. DEBRUS ; C. PROTOPOPESCU ; K. NDIAYE ; B. DEMOULIN ; C. LIONS ; A. HAAS ; M. MORA ; B. SPIRE ; M. SUZAN-MONTI ; M. P. CARRIERI |ENGLISH: Aims: To study the effectiveness of an educational intervention on risks associated with drug injection, comparing primary [unsafe HIV-hepatitis C virus (HCV) practices] and secondary (local complications at injecting site) end-points [...]![]()
Article : Périodique
L. MICHEL ; C. LIONS ; S. VAN MALDEREN ; J. SCHILTZ ; W. VANDERPLASSCHEN ; K. HOLM ; T. KOLIND ; F. NAVA ; N. WELTZIEN ; A. MOSER ; M. JAUFFRET-ROUSTIDE ; O. MAGUET ; P. CARRIERI ; C. BRENTARI ; H. STÖVER |BACKGROUND: Prisoners constitute a high-risk population, particularly for infectious diseases. The aim of this study was to estimate the level of infectious risk in the prisons of five different European countries by measuring to what extent the[...]![]()
Article : Périodique
M. P. CARRIERI ; L. MICHEL ; C. LIONS ; J. COHEN ; M. VRAY ; M. MORA ; F. MARCELLIN ; B. SPIRE ; A. MOREL ; P. ROUX ; The Methaville Study Group |Objective: Methadone coverage is poor in many countries due in part to methadone induction being possible only in specialized care (SC). This multicenter pragmatic trial compared the effectiveness of methadone treatment between two induction mod[...]![]()
Article : Périodique
A. MAYET ; C. LIONS ; P. ROUX ; M. MORA ; G. MARADAN ; A. MOREL ; L. MICHEL ; C. MARIMOUTOU ; M. P. CARRIERI |Introduction: Concurrent cannabis use is very frequent among opioid users on methadone maintenance treatment (MMT), which could reflect a coping strategy during MMT. The aims of this study were to describe variations in cannabis use and to explo[...]